[CAS NO. 250612-42-1]  Cyclo(RGDyK)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [250612-42-1]

Store
Catalog
SLK-S7844
Brand
Selleck
CAS
250612-42-1

DESCRIPTION [250612-42-1]

Overview

MDLMFCD20134101
Molecular Weight847.72
Molecular FormulaC31H43F6N9O12
SMILESO=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C[C@@H](C(N[C@H](CC1=CC=C(O)C=C1)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(NC2)=O)=O)=O)=O)NC2=O

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.1796 mL5.8982 mL11.7963 mL
5 mM0.2359 mL1.1796 mL2.3593 mL
10 mM0.1180 mL0.5898 mL1.1796 mL
50 mM0.0236 mL0.1180 mL0.2359 mL

Description

Cyclo(RGDyK) is a potent and selective inhibitor with of 20 nM.

Targets

αVβ3 integrin [1]
20 nM

In vitro

Cyclo(RGDyK) shows high affinity and selectivity for αVβ3 over αVβ5 and αIIbβ3. Cyclo(RGDyK)-conjugated micelles (TPM) facilitated the cell-specific uptake of DiI into B16-F10 cells and HUVECs via integrin-mediated endocytosis compared with Cyclo(RGDyK) -free micelles (NPM).

In vivo

In apoE−/− mice, Cyclo(RGDyK) (1 nmol, i.v.) inhibits the increase of αVβ3 integrin expression in the intima of the left stenotic carotid artery.